Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats

Taipei Medical University Institutional Repository > 醫學科技學院 > 醫學檢驗暨生物技術學系所 > 期刊論文 > Item 987654321/3774

請使用永久網址來引用或連結此文件: http://libir.tmu.edu.tw/handle/987654321/3774

題名:	Neuroprotective mechanisms of puerarin in middle cerebral artery occlusion-induced brain infarction in rats
作者:	陳健民 Chang Yi;Hsieh CY;Peng ZA;Yen TL;Hsiao Gerorge;ChouDS;Chen CM;Sheu JR
貢獻者:	醫學檢驗暨生物技術學系
日期:	2009
上傳時間:	2009-08-25 10:38:42 (UTC+8)
摘要:	Puerarin, a major isoflavonoid derived from the Chinese medical herb Radix puerariae (kudzu root), has been reported to be useful in the treatment of various cardiovascular diseases. In the present study, we examined the detailed mechanisms underlying the inhibitory effects of puerarin on inflammatory and apoptotic responses induced by middle cerebral artery occlusion (MCAO) in rats. Treatment of puerarin (25 and 50 mg/kg; intraperitoneally) 10 min before MCAO dose-dependently attenuated focal cerebral ischemia in rats. Administration of puerarin at 50 mg/kg, showed marked reduction in infarct size compared with that of control rats. MCAO-induced focal cerebral ischemia was associated with increases in hypoxia-inducible factor-1alpha (HIF-1alpha), inducible nitric oxide synthase (iNOS), and active caspase-3 protein expressions as well as the mRNA expression of tumor necrosis factor-alpha (TNF-alpha) in ischemic regions. These expressions were markedly inhibited by the treatment of puerarin (50 mg/kg). In addition, puerarin (10-50 microM) concentration-dependently inhibited respiratory bursts in human neutrophils stimulated by formyl-Met-Leu-Phe. On the other hand, puerarin (20-500 microM) did not significantly inhibit the thiobarbituric acid-reactive substance reaction in rat brain homogenates. An electron spin resonance (ESR) method was conducted on the scavenging activity of puerarin on the free radicals formed. Puerarin (200 and 500 microM) did not reduce the ESR signal intensity of hydroxyl radical formation. In conclusion, we demonstrate that puerarin is a potent neuroprotective agent on MCAO-induced focal cerebral ischemia in vivo. This effect may be mediated, at least in part, by the inhibition of both HIF-1alpha and TNF-alpha activation, followed by the inhibition of inflammatory responses (i.e., iNOS expression), apoptosis formation (active caspase-3), and neutrophil activation, resulting in a reduction in the infarct volume in ischemia-reperfusion brain injury. Thus, puerarin treatment may represent a novel approach to lowering the risk of or improving function in ischemia-reperfusion brain injury-related disorders.
關聯:	Journal of Biomedical Science.(16).
資料類型:	article
顯示於類別:	[醫學檢驗暨生物技術學系所] 期刊論文

文件中的檔案:

檔案	大小	格式	瀏覽次數
304.pdf	965Kb	Adobe PDF	109	檢視/開啟
全文.txt	0Kb	Text	255	檢視/開啟
摘要.pdf	35Kb	Adobe PDF	139	檢視/開啟

在TMUIR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....